Page last updated: 2024-11-07

prednisone and Glycogen Storage Disease Type V

prednisone has been researched along with Glycogen Storage Disease Type V in 2 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Glycogen Storage Disease Type V: Glycogenosis due to muscle phosphorylase deficiency. Characterized by painful cramps following sustained exercise.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jerusalem, F1
Higgs, JB1
Blaivas, M1
Albers, JW1

Reviews

1 review available for prednisone and Glycogen Storage Disease Type V

ArticleYear
[Treatment of myopathies and spinal muscular atrophies (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1978, Jan-24, Volume: 67, Issue:4

    Topics: Amyotrophic Lateral Sclerosis; Azathioprine; Collagen Diseases; Dermatomyositis; Glycogen Storage Di

1978

Other Studies

1 other study available for prednisone and Glycogen Storage Disease Type V

ArticleYear
McArdle's disease presenting as treatment resistant polymyositis.
    The Journal of rheumatology, 1989, Volume: 16, Issue:12

    Topics: Adult; Biopsy; Diagnosis, Differential; Drug Resistance; Exercise; Female; Glycogen Storage Disease

1989
chemdatabank.com